Table IV.
Relationship between XRCC1-280 gene polymorphism and clinical characteristics of HCC.
| XRCC1-280 (n, %) | ||||
|---|---|---|---|---|
| Clinical features | AA | GG | χ2 | P-value |
| General typing | 5.095 | 0.078 | ||
| Giant block type | 13 (23.64) | 42 (76.36) | ||
| Nodular type | 14 (28.00) | 36 (72.00) | ||
| Diffuse type | 8 (11.94) | 59 (88.06) | ||
| No. of tumors | 6.792 | 0.009 | ||
| Single tumor | 24 (16.55) | 121 (83.45) | ||
| Multiple tumors | 11 (40.74) | 16 (59.26) | ||
| Tumor location in the liver | 10.902 | 0.004 | ||
| Left lobe | 15 (18.99) | 64 (81.01) | ||
| Right lobe | 10 (14.49) | 59 (85.51) | ||
| Other | 11 (45.83) | 13 (54.17) | ||
| Tumor diameter | 11.238 | 0.003 | ||
| <5 cm | 15 (18.75) | 65 (81.25) | ||
| 5-10 cm | 12 (15.79) | 64 (84.21) | ||
| >10 cm | 8 (50.00) | 8 (50.00) | ||
| Capsule invasion | 2.907 | 0.088 | ||
| Yes | 17 (28.33) | 43 (71.67) | ||
| No | 18 (16.07) | 94 (83.93) | ||
XRCC1, X-ray repair cross-complementing 1; HCC, hepatocellular carcinoma.